Literature DB >> 7350374

Hypoparathyroidism and pregnancy. Treatment with calcitriol.

A Sadeghi-Nejad, J I Wolfsdorf, B Senior.   

Abstract

Calcitriol was used successfully to treat a patient with hypoparathyroidism during pregnancy. Increasing dosage of calcitriol were needed during the last trimester with a prompt decrease in the requirement after delivery. The dosage changes appear to mirror the pattern of endogenous synthesis of calcitriol in normal pregnant women.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7350374

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


  5 in total

1.  Thyroid nodule and differentiated thyroid cancer management in pregnancy. An Italian Association of Clinical Endocrinologists (AME) and Italian Thyroid Association (AIT) Joint Statement for Clinical Practice.

Authors:  E Papini; R Negro; A Pinchera; R Guglielmi; A Baroli; P Beck-Peccoz; P Garofalo; M P Pisoni; M Zini; R Elisei; L Chiovato
Journal:  J Endocrinol Invest       Date:  2010-07-13       Impact factor: 4.256

Review 2.  Parathyroid Disease in Pregnancy and Lactation: A Narrative Review of the Literature.

Authors:  Elena Tsourdi; Athanasios D Anastasilakis
Journal:  Biomedicines       Date:  2021-04-26

3.  Calcium and bone disorders in pregnancy.

Authors:  Shriraam Mahadevan; V Kumaravel; R Bharath
Journal:  Indian J Endocrinol Metab       Date:  2012-05

4.  Management of hypoparathyroidism in pregnancy and lactation - A report of 10 cases.

Authors:  B L Hatswell; C A Allan; J Teng; P Wong; P R Ebeling; E M Wallace; P J Fuller; F Milat
Journal:  Bone Rep       Date:  2015-06-30

Review 5.  Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus.

Authors:  Aliya A Khan; Christian A Koch; Stan Van Uum; Jean Patrice Baillargeon; Jens Bollerslev; Maria Luisa Brandi; Claudio Marcocci; Lars Rejnmark; Rene Rizzoli; M Zakarea Shrayyef; Rajesh Thakker; Bulent O Yildiz; Bart Clarke
Journal:  Eur J Endocrinol       Date:  2019-03       Impact factor: 6.664
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.